Guselkumab
Discovery
Development
Clinical
Filed
Commercialized
Therapeutic area
Therapeutic area
Immunology
Reference product
Reference product
Tremfya® (J&J)
Commercial partners
Commercial partners
MS Pharma, Libbs
Status
Status
Development
About this program
Guselkumab is a biosimilar developed to match Tremfya®, a reference biologic used in the treatment of Plaque Psoriasis, Psoriatic Arthritis and other immunological indications.
Commercialization partners
MS-Pharma
Middle East
Libbs
Brazil
Let's build together.
If you want to explore what a partnership with us could look like, we're ready to talk.